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Temperature susceptibilityIn 1998, an enterovirus 71 (EV71) epidemic in Taiwan resulted in 78 deaths; however, the molecular basis of
EV71 pathogenicity remains poorly understood. Comparison of the deduced amino acid sequences in 3D
polymerases of EV71clinical isolates showed the T251V or T251I substitution from 1986 and 1998 outbreaks.
An EV71 replicon system showed that introducing an I251T mutation did not affect luciferase activities at
35 °C when compared with wild type; however, lower luciferase activities were observed when they were
incubated at 39.5 °C. In addition, the I251T mutation in the EV71 infectious clone not only reduced viral
replication at 39.5 °C in vitro but also decreased the virulence of the mouse adaptive strain MP4 in neonatal
mice in an i.p. infection model. Therefore, these results suggested that the threonine at position 251 results
in a temperature sensitivity phenotype of EV71 which may contribute to the attenuation of circulating
strains.
© 2009 Elsevier Inc. All rights reserved.Introduction
Enterovirus 71 (EV71) belongs to the Picornaviridae family and is
the causative agent of hand, foot and mouth disease (HFMD) and
herpangina. In addition, EV71 can cause severe neurological diseases
including encephalitis, meningitis, acute ﬂaccid paralysis and death in
children. The pathogenicity of EV71 is not fully understood. Currently,
vaccine therapy and antiviral agents are not available for EV71
infection.
EV71 was ﬁrst isolated and characterized from patients with
neurological disease in California in 1969, and subsequent outbreaks
occurred in numerous countries including Bulgaria, Hungary and
Malaysia (Ho, 2000). The most severe outbreak occurred in 1998
resulting in 78 deaths in Taiwan and subsequently an average of 40
fatalities occurred each year between 2001 and 2005. Prior to the
outbreak in 1998, sporadic cases of EV71 infection were reported infoot and mouth disease; UTR,
perature sensitive.
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ll rights reserved.1980 and 1986 (Lin et al., 2006). In 1980, EV71 infected children had
poliomyelitis-like ﬂaccid paralysis, HFMD or herpangina; however,
these cases were not associated with death (Ho et al., 1999). EV71
were isolated from patients with HFMD or herpangina in 1986. It was
suggested that aside from host factors, the increased virulence of
EV71, which resulted in severe clinical manifestations in 1998, was
due in part to the evolution of the viral genome (Lin et al., 2003).
Unfortunately, the molecular determinants of EV71 virulence have
not been deﬁned.
Previous studies have shown the importance of the 3D region,
which encodes the RNA dependent RNA polymerase, in virus
replication. Besides incorporation of nucleotides during RNA elonga-
tion (Baltimore, 1964), the 3D polymerase is responsible for
uridylylation of the protein primer, Vpg, which is essential for the
initiation of replication (Flanegan and Baltimore, 1977; Paul et al.,
1998). Furthermore, the 3CD proteinase, which is the precursor of 3D
polymerase, processes the viral polyprotein (Jore et al., 1988; Ypma-
Wong et al., 1988), stabilizes RNP complex with the 5′ cloverleaf and
3AB (Bedard and Semler, 2004) and promotes viral protein matura-
tion and RNA synthesis, respectively. The nuclear localization signal in
the 3D region directs 3CD to the host cell nucleus and 3C shut off the
host cell transcription machinery while it is excised from 3CD
(Weidman et al., 2003). Recent studies also suggested that the low
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which aids in the survival of the virus population in the presence of
selective pressure (Pfeiffer and Kirkegaard, 2005). Mutations in 3D
region of poliovirus resulted in a changing growth rate, viral RNA
accumulation, temperature susceptibility and viral attenuation in
mice (Agut et al., 1989; Burns et al., 1989; Diamond and Kirkegaard,
1994; Toyoda et al., 1987). Therefore, we reasoned that the 3D region
of EV71 may be important in altering the virulence of the virus.
The replicon system, in which the coding sequence of the
structural genes were replaced with a reporter gene, has been used
to study the replication and translation of various plus-stranded RNA
viruses, such as hepatitis C virus, West Nile virus, yellow fever virus
and human enterovirus (Kaplan and Racaniello, 1988; Molenkamp et
al., 2003; Moradpour et al., 2004; Yamshchikov et al., 2001; Yi et al.,
2002). The replicon system has been used to analyze poliovirus virus
replication, tissue tropism and construct foreign gene delivery vectors
(Ansardi et al., 1994a, 1994b; Arita et al., 2006; Bledsoe et al., 2000;
Johansen and Morrow, 2000; Porter et al., 1998; Porter et al., 1997).
These replicon systems have been a useful tool to test vaccine
candidates or to analyze biological properties of viruses.
In this study, we constructed an EV71 replicon with the capsid
region replaced by the ﬁreﬂy luciferase reporter gene. In addition,
recombinant viruses produced from the EV71 infectious clone were
used to study the viral phenotype without interference of other
mutations generated during viral passage. Our results showed that
3D-I251T mutation resulted in a strong temperature-sensitive
phenotype. This phenomenon suggested the presence of the I251T
mutation within the 3D region might contribute to attenuation in
virulence of clinical virus isolates.
Results
Analysis of the 3D regions of EV71 clinical isolates
The 3D regions of EV71 clinical isolates from 1986, 1998 and after
1998 outbreaks were sequenced and compared. The result of 3D
amino acid sequence alignment indicated a T to I or T to V substitution
at position 251 among isolates from and after 1998 outbreaks (Fig. 1).Fig. 1. Alignment of partial 3D amino acid sequences of EV71 clinical isolates from 1986, 19
sequences and aligned using Vector NTI, and the ﬁgure was generated with BioEdit. The I251T
location/year.All of the clinical isolates from 1986 had threonine at position 251 in
3D, and their biological properties are distinct from those isolates
containing a valine or isoleucine at position 251. We next generated
3D-I251T mutation into the EV71 replicon and infectious clone
systems to examine the effect of this substitution on viral biological
characteristics.
Replication of 3Dpol mutant replicon
To examine the effect of the 3D mutation on RNA replication in
cultured SK-N-SH cells in the absence of virus production, EV71
wild-type replicons were constructed (Fig. 2A). An infectious cDNA
clone containing EV71 genome from 1998 isolate was obtained, and
the P1 structure region was replaced with ﬁreﬂy luciferase gene
(Figs. 2B and C). This pT7-driven replicon RNA could be transcribed
in vitro and displayed a time-dependent increase of luciferase
activity when transfected into SK-N-SH cells with a peak at 8 h
posttransfection (data not shown). The results revealed the EV71
replicon RNA could replicate and translate well in SK-N-SH cells,
simulating the life cycle of enterovirus after uncoating. The I251T
mutant 3Dpol coding sequences were subcloned into the EV71-
luciferase replicon (Fig. 2C) to determine the effect on replication.
In addition to the 3D-I251T mutant replicon, a 3Dpol gene-deleted
construct was also generated which could be translated but could
not replicate while transfected into cells. Thus, a basal level of
luciferase activity was still expected and would reﬂect an input RNA
translation level (data not shown). In addition, another mutation
D328H which results in a distinct replication defect in poliovirus
was also introduced to the EV71 replicon. RNA of this construct was
transcribed and translated in vitro and displayed high luciferase
activities with no difference from wild type (Fig. 3A). The results
suggested that the in vitro transcribed RNA could be translated into
protein successfully and there was no discrepancy in the translation
of RNA derived from those construct. Transfection of 3D-deleted
construct and D328H replicon RNA into SK-N-SH cells resulted in
low luciferase activities (Fig. 3B). Moreover, there was no signiﬁcant
difference of luciferase activities between wild-type and 3D-I251T
mutant replicon at 35 °C (Fig. 3B). However, the 3D-I251T mutant98 and post-1998 outbreaks. The amino acid sequences were deduced from nucleotide
mutation is highlighted by the black frame. Viruses were designated as isolate number/
Fig. 2. Schematic diagram of EV71 infectious clones and replicons. (A) Construction scheme for wild-type EV71 replicon. Luc, ﬁreﬂy luciferase; NS, nonstructural region; Kanr, kanamycin resistant; Apr, ampicillin resistant; Δ3D, 3D region













Fig. 3. Translation and replication of EV71 replicon RNA as measured by luciferase activities. (A) Luciferase activities of EV71 replicons following in vitro translation using the rabbit
reticulocyte lysate system. (B) Luciferase activities of EV71 replicons following RNA transfection into SK-N-SH cells for 8 h at varying temperatures. Transfection of EV71 infectious
clones in SK-N-SH cells at (C) 35 °C and 39.5 °C. Virus titer of the supernatant determined by plaque assay was presented in (D). The data shown were from triplicate experiments,
expressed as the mean±SD. ⁎pb0.05 in a t test.
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activities when compared with wild type at 39.5 °C (Fig. 3B),
suggesting that 3D-I251T mutant might inﬂuence the 3D polymer-
ase activities at the higher temperature.
Effects of I251T polymerase mutations on EV71 infectious clone
To test the ability of themutant polymerases to support replication
in vivo, the mutant 3Dpol genes were subcloned into an infectious
clone of EV71 and the RNA was transfected into SK-N-SH cells. After
transfection, the RNA from wild-type EV71 infectious clone RNA at
35 °C displayed a typical cytopathic effect of enterovirus in SK-N-SH
cells at day 3 posttransfection. Production of recombinant EV71 was
conﬁrmed by immunoﬂuorescence staining using EV71 monoclonal
antibody (Fig. 3C). The cell culture supernatant was also collected and
inoculated into SK-N-SH cell monolayer to insure the generation of
infectious virus particles. The virus production of 3D-I251T mutant
infectious clone was not different from wild type when cultured at
35 °C. However, the 3D-I251T mutant infectious clone presented a
100-fold decrease in virus progeny at 39.5 °C (Fig. 3D). These results
indicated that 3D-I251T mutant polymerase might not effectively
support replication at a higher temperature.
Phenotypes of EV71 carrying I251T polymerase mutation
To further investigate the effect of 3D mutation on EV71 biological
characteristics, viruses were harvested from cell culture transfected
with RNA from the infectious clone. Growth kinetics and plaque
phenotype showed no difference between wild-type and the 3D-I251T
mutant viruses at 35 °C (Fig. 4A). Interestingly, the growth kinetics of
3D-I251T mutant viruses displayed lagging growth rates and smaller
plaques than the wild type when grown in SK-N-SH cells at 39.5 °C(Figs. 4B and C). Temperature-sensitivity tests were also carried out by
measuring the virus titer in SK-N-SH cells at 35 or 39.5 °C. Thewild-type
neu strain EV71 displayed a temperature-sensitive phenotype, while
the 3D-I251T mutation conferred a strong temperature-sensitive
phenotype (Table 1). Notably, EV71 isolates from 1986 (237-TW-86
and 242-TW-86) also displayed a strong temperature-sensitive pheno-
type. These results indicated that 3D-I251T might serve as the
temperature sensitivity determinant in the genetic context of EV71.
Next, we investigated whether the I251T correlated with EV71
virulence in addition to its role as a determinant of temperature
sensitivity. We generated the infectious clone MP4/y-5 using mouse-
adapted EV71 strain MP4 as backbone and introduced the I251T
mutation into MP4/y-5 to examine the attenuated effect of the I251T
mutation to mice. The recombinant MP4 viruses were inoculated into
1-day-old ICR mice intraperitoneally and the virulence of the virus in
neonatal mice was analyzed. The results revealed that 86% of the mice
were dead on day 4 postinfection and none survived on day 5
postinfection (Fig. 4D). In contrast, mice infected with MP4 carrying
I251Tmutation survived up to 5 days postinfection, an indication of the
attenuation of the virus in neonatal mice. Moreover, the results of
clinical score indicated that the I251Tmutation signiﬁcantly delayed the
paralysis progression whereas the average clinical scores decreased
from 5 to 4 on day 4 postinfection (Fig. 4E). According to these results,
we suggested that 3D-I251T mutant in the genetic context of EV71
would increase the viral temperature susceptibility in neuron cells and
attenuate the virulence of EV71 in the neonatal mice infection model.
Discussions
EV71 has circulated in Taiwan for more than one decade. Two
mild EV71 epidemics that occurred in 1980 and 1986 resulted in
HFMD, herpangina and a few cases of poliomyelitis-like ﬂaccid
Fig. 4. Biological characteristics of the EV71 3Dmutant. (A) Growth kinetics of EV71wild-type and I251Tmutant at 35 °C, MOI=10. (B) Growth kinetics of EV71 wild-type and I251T
mutant at 39.5 °C, MOI=20. (C) Plaque phenotype of EV71wild-type and I251Tmutant at 35 and 39.5 °C. L, Large-plaque phenotype; M,medium-plaque phenotype; S, small-plaque
phenotype. (D) Inoculation of EV71 wild-type and I251T mutant into one-day-old ICR mice intraperitoneally. The survival rates are indicated.
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outbreak in 1998 resulted in 78 deaths and 405 severe cases with
neurological symptoms, pulmonary edema and acute ﬂaccid paral-
ysis (Ho et al., 1999). Serological evidence showed that age-speciﬁc
pre-epidemic EV71 seroprevalence rates were inversely correlated
with age-speciﬁc enterovirus-related mortality rates (Chang et al.,
2002). Also, clinical observations during the outbreaks revealed that
small children were infected more frequently and had more severe
clinical manifestations than older children and adults, suggesting
that pre-existing neutralizing antibodies might offer protective
immunity against EV71 infection (Lu et al., 2002), and that numerous
host factors were associated with clinical presentations (Lin et al.,
2003). On the other hand, increasing viral virulence due to evolution
of the virus might be one of the primary contributors to serious
epidemics. Currently, the genetic determinants of EV71 virulence are
poorly understood. The goal of this study was to determine the
molecular determinant(s) of EV71 virulence which may have
contributed to the 1998 outbreak. The 5′-UTR of poliovirus,
necessary for RNA replication and translation in many organs, was
reported to determine virulence phenotype (Kauder and Racaniello,
2004; Kawamura et al., 1989). Determinants of coxsackievirus B3
cardiovirulence phenotype have been localized to the 5′-UTR (Lee etTable 1
Temperature sensitivity of mutant EV71 strains.
Viruses Titer ΔLog Phenotype
35 °C 39.5 °C
237-TW-86 7.33a 1a 6.33 Strong TS
242-TW-86 7.33a 1.33a 6 Strong TS
neu-TW-98 6.24b 3.73b 2.51 TS
neu-TW-98-I251T 6.68b 2.05b 4.63 Strong TS
a Virus titer represents log10(TCID50) in 10-μl virus suspension.
b Virus titer represents log10(PFU) in 1-ml virus suspension. Δlog ≤2, temperature
resistant, TR; Δlog N2, temperature sensitive, TS; Δlog N2.75, strong temperature
sensitive, strong TS.al., 1997; Tu et al., 1995) and capsid region (Knowlton et al., 1996). A
mutation in the 2A protease of swine vesicular disease virus affecting
eIF4GI cleavage resulted in a change in virulence of the virus (Inoue
et al., 2005; Kanno et al., 1999). Protease 3C was responsible for
triggering apoptosis in poliovirus-infected cells by a mechanism that
involved caspase activation (Barco et al., 2000). The Y73H mutation
in 3D polymerase of poliovirus type 1 contributed to virus
attenuation in mice (Tardy-Panit et al., 1993).
Our study focused on variations of the 3D region of EV71 strains
isolated between 1986 and 1998. Sequence alignment of the 3D
regions revealed numerous amino changes between EV71 isolates
from 1986 and those from or after 1998. The majority of amino acid
changes were inter-genotypic variations except position 251. EV71
isolated from 1986 had a hydrophilic amino acid, threonine, in
position 251 in contrast to those isolated from 1998 with a
hydrophobic amino acid, either isoleucine or valine. Therefore, our
primary objective was to identify the effect of introducing a 3D-I251T
mutation to the EV71 replicon and infectious clone systems with the
1998 strain as the backbone. Moreover, a well-deﬁned substitution at
3D position 328was used as a control. The D328Hmutation seemed to
have no effects on replicon RNA translation in vitro suggesting that
D328Hmight not act at the level of viral RNA translation. Transfection
of the 3D-D328H mutant replicon or infectious clone RNA into SK-N-
SH cells caused low-level luciferase activities and no infectious viral
progeny, respectively. The luciferase activities brought out by D328H
and Δ3D replicon RNA transfection was similar to basal translation
level, indicating RNA replication was abolished. Previous studies
showed D328 was the ﬁrst aspartic acid located in the GDD motif of
the palm subdomain of RNA-dependent RNA polymerase, which was
highly conserved within plus-stranded RNA viruses (Jablonski and
Morrow, 1995). The D residue was suggested to be exposed on the
loop region of β-turn-β conformation by structural prediction (Argos,
1988). The two aspartic acids in the GDD motif have been postulated
to be involved in metal ion coordination at or near the catalytic active
site of the enzyme (Argos, 1988; Delarue et al., 1990). The substitution
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in vivo (Jablonski andMorrow, 1995; Ribas andWickner, 1992; Sankar
and Porter, 1992). Taken together, our results were agreed with these
previous ﬁndings, indicating that D328 was required for polymerase
activity of EV71 and most plus-stranded RNA viruses.
In this study, we identiﬁed a novel genetic determinant at position
251 which was never studied in other enteroviruses. A single point
mutationof this position reducedEV71 replication ratedup to 100-fold
at high temperature. In addition, EV71 1998 strain became strong
temperature sensitive when the 3D 251 position had an I to T
substitution and this substitution was also identiﬁed in the 1986
strains. This result revealed the substitution of position 251 in 3D was
the region responsible for partial change of temperature susceptibility
from 1986 to 1998. Position 251 is located in the α-helix between the
ﬁngers subdomain and the A motif of the palm subdomain (O'Reilly
andKao, 1998). Structure predictiondisplayed no obvious alteration in
3D polymerase structure when I change to T at position 251 (by PS2
software) (data not shown). Studies of poliovirus showed that
mutations in the highly conserved regions, 5′-UTR, 3D and 3′-UTR
(Kawamura et al., 1989; Omata et al., 1986), acting together or
independently could affect temperature susceptibility (Bouchard et al.,
1995). Introducing those temperature-sensitive determinants of Sabin
1 into EV71 BrCr-TR strain also caused defective viral replication at
nonpermissive temperatures. EV71 demonstrated a strong tempera-
ture-sensitive phenotype as a result of three mutations, Y73H and
C363I in 3D and A7049G in the 3′-UTR (Arita et al., 2005). According to
thoseﬁndings, PV1 and EV71 shared a commongenetic determinant of
temperature sensitivity.
Although none of the in vitro phenotypic markers alone can serve
as a good indicator of neurovirulence or attenuation (Omata et al.,
1986), temperature sensitivity of PV vaccine strains serves as an in
vitro attenuation marker in general. A total of 53 strains isolated from
1998 were analyzed for the phenotype of temperature susceptibility.
The results showed that 22.6% of the viruses were temperature
resistant, while 77.4% of the viruses isolated were temperature
sensitive (data not shown). According to our data, 36.7% (11/30) of
EV71 clinical strains isolated from patient with CNS involvement or
death were temperature resistant; in contrast, there was only about
4.3% (1/23) which were temperature-resistant among those isolates
from HFMD. These results suggested that EV71 with temperature-
resistant phenotype could replicate more efﬁciently in neuron cells
in the patients with fever; thus, they were more virulent and caused
more severe neurological diseases. In the another study of EV71
infection in mice, a G145E mutation in VP1 capsid protein was found
to be essential for mouse-adapted EV71 virus to infect NOD/SCID
mouse and to cause paralysis of the infected mice and suggested that
the capsid proteins played an important role for EV71 to cross the
species barrier between human and mouse (Arita et al., 2008). The
same mouse virulence determinant was also found in newborn
BALB/c mice infection model (Chua et al., 2008). Therefore, to
examine the attenuation effect of position 251 mutation of 3D
polymerase in mouse infection model, we further used mouse-
adapted strain MP4 as template and constructed the MP4/y-5
infectious clone which also has glutamate at position 145 in VP1
and the generated virus displayed virulence to neonatal mice. The
MP4/y-5 virus with I251T substitution resulted in attenuation and
prolonged the survival time of infected mice. Although this mutation
only delayed the death of infectedmouse for one day,we suggested the
I251T mutation affected the virulence of EV71 which correlated with
lower viral replication at high temperature in vivo in neurons.
Therefore, with the cooperation of the capsid region for cell entry,
we speculated that I251T mutation might be one of the potential
determinants for the viral virulence. This ﬁnding might explain the
increase in viral virulence in the 1998 outbreak in Taiwan as a result of
the change from threonine to isoleucine at position 251. In addition,
these results might be useful for EV71 vaccine development.In conclusion, we set up an EV71 replicon system with the ﬁreﬂy
luciferase reporter gene which could rapidly estimate the level of the
viral replication. After comparing the 3D regions of EV71 strains from
1986 and 1998, we identiﬁed a novel determinant at position 251,
which was probably responsible for alternation of temperature
susceptibility and viral virulence. I251T substitution might explain
the increase in viral virulence of the virus in the 1998 outbreak.Materials and methods
Cells and viruses
SK-N-SH cells (ATCC no. HTB-11) were grown in Dulbecco's
modiﬁed Eagle's medium (DMEM, Gibco, BRL, Grand Island, NY)
(supplemented with 10% FBS, 100 u/ml penicillin, 100 μg/ml
streptomycin) and incubated at 35 °C with 5% CO2. EV71 clinical
isolates and recombinant viruses were propagated in SK-N-SH cells.
Virus titration, growth kinetics and temperature sensitivity tests were
also performed using SK-N-SH cells.
RNA extraction, RT-PCR and sequencing
EV71-infected SK-N-SH cells with 75% cytopathic effect were
scraped and pelleted by centrifugation. Viral genomic RNA was
extracted from the pellet of infected cells by using a Viral Nucleic
Acid Extraction Kit (Geneaid, Taipei County, Taiwan). RT-PCR was
performed by using MMLV reverse transcriptase (Promega, Madison,
WI) and the 3D-7360R primer for reverse transcription. Primers
including 3D-5809F and 3D-7360R were used to amplify the 3D
region by using Taq DNA polymerase (New England Biolabs, Beverly,
MA). PCR products were puriﬁed by using a QIAquick Gel Extraction
Kit (Qiagen, Valencia, CA) and sequenced. The amino acid sequences
were deduced from the nucleotide sequences and aligned using
Vector NTI. The 3D region of the following EV71 strains were deduced
from sequences retrieved from GenBank: BrCr-CA-70 (Q66478),
7423/MS/87 (Q66479), UH1/PM/97 (CAL36656), 2086/TW/98
(AAD22046), 4643/TW/98 (AAG24906), 5746/TW/98 (AAG24905),
6092/TW/98 (AAG24907), Neu/TW/98 (AAY59418), 5556/SIN/00
(AAK30618) and 5865/SIN/00 (AAK13008). Sequencing was per-
formed for the following strains: 236/TW/86 (FJ357379), 237/TW/86
(FJ357380), 242/TW/86 (FJ415467), 244/TW/86 (FJ357381), 252/
TW/86 (FJ357383), 266/TW/86 (FJ357384), 5145/TW/98
(FJ415462), 5774/TW/98 (FJ415463), 5811/TW/98 (FJ415464),
6360/TW/98 (FJ415466), 6717/TW/98 (FJ415465), MP4 (mouse-
adapted enterovirus 71 4643/TW/98 strain) (Wang et al., 2004),
1034/TW/00 (FJ415457), 1059/TW/00 (FJ415458), 1643/TW/00
(FJ415459), 2443/TW/02 (FJ415460) and 3496/TW/02 (FJ415461).
Construction of EV71 replicon and infectious clone
The complete 5′-UTR region of the EV71 4643 strain and ﬁreﬂy
luciferase gene were ampliﬁed using 4643-F (containing T7 promoter
upstream of 5′-UTR), 5′UTR-XmaI and Luc-XmaI, Luc-AcsI primers,
respectively (Table 2). The PCR-ampliﬁed T7-5′UTR and ﬁreﬂy
luciferase (Luc) fragments were cloned into pNEB193 vector individ-
ually. The T7-5′UTR fragment of pNEB193-T7-5′UTR plasmid was
subcloned into pNEB193-Luc plasmid following EcoRI and XmaI
digestion. In order to change the plasmid backbone to pBR322 vector,
a novel vector with AcsI restriction enzyme site was generated. The
multiple cloning sites (MCS) of pNEB193 vector was digested with
EcoRI and HindIII and then cloned into pBR322 vector. The new
vector containing pBR322 vector backbone and pNEB193 vector MCS
was named pCAM. T7-5′UTR-Luc fragment was digested with EcoRI
and AcsI and then ligated into pCAM. Nonstructural region (NS) and
the 3′UTR from the EV71 infectious clone neu strain was subcloned
Table 2
EV71 primers used in this study.
Sequences underlined represent restriction enzyme cutting site; hollow square shows T7 promoter and block letters indicate the positions of nucleotide substitutions.
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sites (Shih et al., 2004). The pCAM-T7-5′UTR-Luc-NS-3′UTR plasmid
was sequenced and conﬁrmed to contain the EV71 full-length genome
with the structural region replaced by ﬁreﬂy luciferase gene. Amouse-
adapted infectious clone, MP4/y-5, was constructed using the strain
MP4. Viral genomic RNAwas extracted and RT-PCR was performed by
using primer 4643-R-T50 and SuperScript II reverse transcriptase
(Invitrogen, Carlsbad, CA) for reverse transcription, and viral cDNA
was next ampliﬁed using primer 4643-F and 4643-R-T50 by using the
Advantage cDNA polymerase mix (BD Biosciences, Palo Alto, CA) for
PCR. The products were puriﬁed by phenol–chloroform extraction and
then directly cloned using the TOPO XL PCR cloning kit (Invitrogen,
Carlsbad, CA).
Construction of 3D mutant replicons and infectious clones
Mutations, 3D-I251T and 3D-D328H, were introduced into the
replicon or infectious clone using QuikChange XL Site-Directed
Mutagenesis Kit (Stratagene, La Jolla, CA). Themutant oligonucleotide
I251T-F and I251T-R changed nucleotide 6690 (T to C) of wild-type
EV71, resulting in alternation of isoleucine acid to threonine (I251T);
and D328H-F and D328H-R change nucleotide 6923 (G to C), resulting
in alternation of aspartic acid to histidine (D328H). The obtained
mutant 3D fragment was digested with restriction enzymes (DraIII
and PmlI,MluI and NruI for replicon and infectious clone, respectively)
and subcloned into the wild-type replicon and infectious clone.
Primers mentioned above are listed in Table 1.
In vitro transcription
EV71 replicon and infectious clone plasmids were linearized with
EagI and SmaI, respectively. Transcription was performed with T7
RNA polymerase by using a RiboMAX™ Large Scale RNA Production
Systems (Promega, Madison, WI). For translation experiments,
transcription reactions were terminated by addition of RQ1 RNase-
Free DNase. RNAwas extractedwith phenol–chloroform and analyzed
by electrophoresis under denaturing condition in 2.2 M formaldehyde
according to Maniatis et al. (1982) using the MOPS buffer system and
stained with ethidium bromide.
Transfections and luciferase assays
Approximately 90% conﬂuentmonolayers of SK-N-SH cells grown in
6-well plates were rinsed twice with phosphate-buffered saline (PBS).
One-microgram RNA was added to TransMessenger Transfection
Reagent (Qiagen Valencia, CA) to a ﬁnal volume of 100 μl. After
incubation for 10 min at room temperature, 0.9 ml of Dulbecco'smodiﬁed Eagle's medium (DMEM) was added, and cultures were
incubated at 35 °C for 4 h. Medium was then replaced with DMEM
supplemented with 10% fetal bovine serum (FBS), and plates were
allowed to incubate at 35 °C for 8 h. At the indicated times, cells were
washed twice with PBS. Cell culture lysis buffer (0.5 ml) (Promega,
Madison, WI) was added to each well, and cells were collected in a 1.5-
ml Eppendorf tube. Aliquots (20 μl) of the supernatantswere used in the
Dual-Glo™ Luciferase Assay System (Promega, Madison, WI), and light
emission was measured with a MiniLumat LB 9506 luminometer
(Berthold, Bad Wildbad, Deutschland). Their relative light units (RLU)
were calculated accordingly.
Immunoﬂuorescent staining
At the indicated times, cells were scraped and ﬁxed on glass slides
with acetone for 10 min. The slides were stained with mouse anti-
EV71 monoclonal antibody (mab979, Chemicon, Billerica, MA), FITC-
conjugated goat anti-mouse IgG antibody and then examined under a
ﬂuorescent microscope.
Plaque assay
The plaque assay was performed in 6-well plates (TPP, Trasadin-
gen, Switzerland) containing SK-N-SH cell monolayer (Dolan et al.,
1968). Ten-fold dilutions of virus suspension were inoculated at
400 μl/well and incubated for 1 h at 35 °C. Virus suspension was
discarded and 2 ml DMEM containing 2% FBS and 1% methylcellulose
(Sigma-Aldrich, St. Louis, MO) was added per well and incubated at
35 °C. After incubation for 4 days, overlay mediumwas discarded, and
cells were ﬁxed in 10% formaldehyde and then stained with 1% crystal
violet.
Replication kinetics
SK-N-SH cell monolayers in culture tube (2×105 cells) were
incubated with virus for 1 h at 35 °C. The cells were washed and then
cultivated in Dulbecco's modiﬁed Eagle's medium containing 2% fetal
bovine serum at 35 °C and 39.5 °C, respectively. Virus titers were
determined at different intervals by a plaque assay using SK-N-SH cell
monolayers in 6-well plates.
Temperature sensitivity
SK-N-SH cell monolayers in culture tube (1×105 cells) were
infected with virus at a multiplicity of infection (MOI) of 10−4 at 35 °C
and 39.5 °C. Virus titers were determined by TCID50 using SK-N-SH
cells after 96 h incubation. Temperature sensitivity was expressed as
8 Y.-H. Kung et al. / Virology 396 (2010) 1–9difference of TCID50 values at 35 and 39.5 °C (ΔTCID50). We deﬁned a
less than 2.0 logarithmic difference as a temperature resistant (tr)
phenotype, those from 2.0 to 2.75 logarithmic difference as a
temperature-sensitive (ts) phenotype and those with more than
2.75 logarithmic difference as a strong ts phenotype (Arita et al., 2005).
In vivo mouse model
Speciﬁc pathogen-free, ICR mice (newborn, the Laboratory Animal
Center, National Cheng Kung University) were inoculated with 100 μl
(i.p.) of different EV71 viruses as indicated. Control animals were
given medium instead of virus. Animals were observed daily for
weight gain or lost, clinical signs and mortality until postinfection
7 days. According to the clinical signs, disease progressions were
scored as follows: 0=health; 1=rufﬂed fur and hunchbacked
appearance; 2=wasting; 3=limb weakness; 4=limb paralysis;
and 5=moribund and death (Chen et al., 2007). The institutional
animal care and use committee approved all animal protocols.
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